109
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Prognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia

, , , &
Pages 492-500 | Received 07 Nov 2007, Accepted 10 Dec 2007, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xiangdong Liu, Robert C Newton & Peggy A Scherle. (2011) Development of c-MET pathway inhibitors. Expert Opinion on Investigational Drugs 20:9, pages 1225-1241.
Read now

Articles from other publishers (13)

M. Arock. (2022) Le polynucléaire basophile : du contrôle de l’immunité à celui des leucémies. Annales Pharmaceutiques Françaises 80:1, pages 9-25.
Crossref
Mrinalini Kotru, Purvi Mathur, Neha Garg, Yogendar Kumar, Meera Sikka & Usha Rusia. (2021) Serum Vascular Endothelial Gowth Factor Correlates with Hasford Score in Chronic Myeloid Leukemia. Indian Journal of Hematology and Blood Transfusion 38:1, pages 61-67.
Crossref
Naofumi Mukaida, Yamato Tanabe & Tomohisa Baba. (2021) Cancer non-stem cells as a potent regulator of tumor microenvironment: a lesson from chronic myeloid leukemia. Molecular Biomedicine 2:1.
Crossref
Caroline Busch & Helen Wheadon. (2019) Bone marrow niche crosses paths with BMPs: a road to protection and persistence in CML. Biochemical Society Transactions 47:5, pages 1307-1325.
Crossref
Masanobu Tsubaki. (2018) MET/ERK and MET/JNK Pathway Activation Is Involved in BCR-ABL Inhibitor-resistance in Chronic Myeloid Leukemia慢性骨髄性白血病でのBCR-ABL阻害薬耐性にMET/ERK及びMET/JNK経路活性化が関与する. YAKUGAKU ZASSHI 138:12, pages 1461-1466.
Crossref
Peter Valent, Hans-Peter Horny & Michel Arock. (2018) The underestimated role of basophils in Ph + chronic myeloid leukaemia . European Journal of Clinical Investigation 48:10, pages e13000.
Crossref
Stina Söderlund, Lisa Christiansson, Inger Persson, Henrik Hjorth-Hansen, Johan Richter, Bengt Simonsson, Satu Mustjoki, Ulla Olsson-Strömberg & Angelica Loskog. (2016) Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli. Leukemia Research 50, pages 95-103.
Crossref
Gregor Hoermann, Georg Greiner & Peter Valent. (2015) Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms. Mediators of Inflammation 2015, pages 1-17.
Crossref
Jianxing Feng, Clifford A. Meyer, Qian Wang, Jun S. Liu, X. Shirley Liu & Yong Zhang. (2012) GFOLD: a generalized fold change for ranking differentially expressed genes from RNA-seq data. Bioinformatics 28:21, pages 2782-2788.
Crossref
Sabine Cerny-Reiterer, Viviane Ghanim, Gregor Hoermann, Karl J. Aichberger, Harald Herrmann, Leonhard Muellauer, Andreas Repa, Christian Sillaber, Andrew F. Walls, Matthias Mayerhofer & Peter Valent. (2012) Identification of Basophils as a Major Source of Hepatocyte Growth Factor in Chronic Myeloid Leukemia: A Novel Mechanism of BCR-ABL1-Independent Disease Progression. Neoplasia 14:7, pages 572-IN10.
Crossref
Solange Peters & Alex A. Adjei. (2012) MET: a promising anticancer therapeutic target. Nature Reviews Clinical Oncology 9:6, pages 314-326.
Crossref
Marco Mineo, Susan H. Garfield, Simona Taverna, Anna Flugy, Giacomo De Leo, Riccardo Alessandro & Elise C. Kohn. (2011) Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a src-dependent fashion. Angiogenesis 15:1, pages 33-45.
Crossref
Thomas SchmidtPeter Carmeliet. (2011) Angiogenesis: A Target in Solid Tumors, Also in Leukemia?. Hematology 2011:1, pages 1-8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.